Bragar Eagel & Squire Urges PomDoctor Investors to Meet April 7 Deadline

Law firm reminds investors of class action lawsuit deadline against PomDoctor over alleged stock promotion scheme.

Apr. 6, 2026 at 9:58pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of legal documents, a gavel, and a calculator on a clean white background, conceptually representing the legal proceedings and financial implications of the alleged stock promotion scheme.A legal case over alleged stock manipulation highlights the growing threat of social media-driven investment schemes targeting retail investors.NYC Today

Bragar Eagel & Squire, P.C., a national stockholder rights law firm, announced that a class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ:POM) in the United States District Court for the Southern District of New York. The lawsuit alleges that PomDoctor engaged in a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as coordinated insider dumping of shares during a price inflation campaign.

Why it matters

This case highlights the growing problem of alleged stock manipulation and pump-and-dump schemes targeting retail investors, which have become more prevalent with the rise of social media-driven trading. The outcome could have significant implications for PomDoctor and set precedents around disclosure requirements for public companies.

The details

The complaint alleges that throughout the Class Period from October 9, 2025 to December 11, 2025, PomDoctor failed to disclose to investors that the company was the subject of a fraudulent stock promotion scheme. This allegedly involved the use of social media-based misinformation, impersonated financial professionals, and coordinated insider dumping of shares during a price inflation campaign. The company's public statements and risk disclosures were also said to have omitted any mention of these issues.

  • The class action lawsuit was filed on April 6, 2026.
  • Investors have until April 7, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized stockholder rights law firm that filed the class action lawsuit against PomDoctor.

Brandon Walker

A litigation partner at Bragar Eagel & Squire who is encouraging PomDoctor investors to contact the firm.

Melissa Fortunato

A Bragar Eagel & Squire partner who is also encouraging PomDoctor investors to contact the firm.

PomDoctor, Ltd.

A publicly traded company (NASDAQ:POM) that is the subject of the class action lawsuit alleging a fraudulent stock promotion scheme.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or acquired PomDoctor securities between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire

What’s next

Investors have until April 7, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit against PomDoctor.

The takeaway

This case highlights the growing problem of alleged stock manipulation and pump-and-dump schemes targeting retail investors, which have become more prevalent with the rise of social media-driven trading. The outcome could have significant implications for PomDoctor and set precedents around disclosure requirements for public companies.